DIO: Enzyme Immunoassay, Cocaine And Cocaine Metabolites
What it covers
A cocaine and cocaine metabolite test system is a device intended to measure cocaine and a cocaine metabolite (benzoylecgonine) in serum, plasma, and urine. Measurements obtained by this device are used in the diagnosis and treatment of cocaine use or overdose.
The identification in 21 CFR 862.3250, cocaine and cocaine metabolite test system. FDA gives DIO no definition of its own, so the regulation’s describes it.
Recent clearances
| 510(k) | Device | Applicant | Decision | Type |
|---|---|---|---|---|
| K213211 | Carolina Liquid Chemistries Cocaine and Cocaine Metabolite Enzyme Immunoassay (COCM) Test System | Carolina Liquid Chemistries Corp. | Jan 27, 2022 | Traditional |
| K211973 | DRI Cocaine Metabolite Assay | Microgenics Corporation | Sep 24, 2021 | Traditional |
| K191638 | Pointe Scientific Cocaine Metabolite Enzyme Immunoassay | Medtest DX | Mar 12, 2020 | Traditional |
| K181499 | DRI Cocaine Metabolite Assay | Microgenics Corporation | Jul 6, 2018 | Traditional |
| K170293 | Emit II Plus Cocaine Metabolite Assay | Siemens Healthcare Diagnostics, Inc. | Oct 25, 2017 | Traditional |
| K163570 | Carolina Liquid Chemistries Cocaine and Cocaine Metabolite Test System (COCM) | Carolina Liquid Chemistries Corporation | Aug 15, 2017 | Traditional |
| K162395 | MP DOA-10 Panel Test Cup, MP DOA-11 Panel Test Cup | Mp Biomedicals, LLC | Jun 2, 2017 | Special |
| K152232 | Quest Diagnostics HairCheck-DT (Cocaine) | Quest Diagnostics Incorporated | Nov 18, 2016 | Traditional |
| K161214 | Wondfo Amphetamine Urine Test AMP 500 (Cup, Dipcard), Wondfo Cocaine Urine Test COC 150(Cup, Dipcard), Wondfo Methamphetamine Urine Test MET 500 (Cup, Dipcard) | Guangzhou Wondfo Biotech Co., Ltd. | Jun 27, 2016 | Traditional |
| K153646 | SAFECARE Urine Test Amphetamine, SAFECARE Urine Test Cocaine, SAFECARE Urine Test Marijuana | Safecare Biotech (Hangzhou) Co., Ltd. | Mar 18, 2016 | Traditional |
Clearances by year
26 DIO 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.
| Year | Clearances | Median days to decision |
|---|---|---|
| 2022 | 1 | 120 |
| 2021 | 1 | 91 |
| 2020 | 1 | 267 |
| 2018 | 1 | 29 |
| 2017 | 3 | 267 |
| 2016 | 3 | 88 |
| 2015 | 2 | 219 |
| 2014 | 2 | 38 |
| 2013 | 2 | 126 |
| 2012 | 5 | 139 |
| 2011 | 5 | 65 |
Who submits
21 applicants cleared a DIO device since 2011. 88% of the clearances went to applicants in United States, then China (8%) and United Kingdom (4%). By type: Traditional 88% and Special 12%.
| Applicant | Clearances since 2011 |
|---|---|
| Guangzhou Wondfo Biotech Co., Ltd. | 4 |
| Microgenics Corporation | 2 |
| Omega Laboratories, Inc. | 2 |
| Ameditech, Inc. | 1 |
| Biophor Diagnostics, Inc. | 1 |
| Branan Medical Corporation | 1 |
| Carolina Liquid Chemistries Corp. | 1 |
| Carolina Liquid Chemistries Corporation | 1 |
How FDA classifies it
Class II (special controls). A cocaine and cocaine metabolite test system is not exempt if it is intended for any use other than employment or insurance testing. The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 862.9, provided the test system is intended for employment and insurance testing and includes a statement in the labeling that the device is intended solely for use in employment and insurance testing.
From 21 CFR 862.3250. Special controls are the requirements a 510(k) must show it meets.
Standards
21 CFR 862.3250 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent DIO clearances declared.
Ask about DIO
Questions about DIO
What is FDA product code DIO?
Product code DIO, “Enzyme Immunoassay, Cocaine And Cocaine Metabolites” in FDA's classification database, is a Class II device type under 21 CFR 862.3250 (cocaine and cocaine metabolite test system), reviewed by FDA's Clinical Toxicology panel. FDA's 510(k) database lists 145 clearances under DIO, 26 of them since 2011.
How many 510(k) clearances are there under DIO?
FDA’s 510(k) database listed 145 clearances under DIO as of Oct 29, 2026, 26 of them decided since 2011; the most recent decision was Jan 27, 2022. The Predicate Finder searches the live database.
Which companies have the most DIO clearances?
Since 2011: Guangzhou Wondfo Biotech Co., Ltd. (4), Microgenics Corporation (2), Omega Laboratories, Inc. (2), Ameditech, Inc. (1) and Biophor Diagnostics, Inc. (1). 21 applicants have cleared a DIO device in that time.